The evolution of mendelian randomization for investigating drug effects

D Gill, S Burgess - PLoS medicine, 2022 - journals.plos.org
Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky
and colleagues investigating the associations between genetically-proxied inhibition of …

A genomic deep field view of hypertension

PS Garimella, C Du Toit, NN Le, S Padmanabhan - Kidney International, 2023 - Elsevier
Blood pressure is regulated by a complex neurohumoral system including the renin-
angiotensin-aldosterone system, natriuretic peptides, endothelial pathways, the sympathetic …

Association between angiotensin-converting enzyme inhibitor-induced cough and the risk of lung cancer: a Mendelian randomization study

T Yao, Z Wu, Z Wang, L Chen, B Liu, M Lu… - Frontiers in …, 2023 - frontiersin.org
Background: Observational studies and meta-analyses have demonstrated a positive
correlation between the use of angiotensin-converting enzyme inhibitors (ACEIs) and lung …

Harnessing the power of electronic health records and genomics for drug discovery

K Krebs, L Milani - Annual Review of Pharmacology and …, 2023 - annualreviews.org
A long-standing recognition that information from human genetics studies has the potential
to accelerate drug discovery has led to decades of research on how to leverage genetic and …

Association between antihypertensive drugs and hepatocellular carcinoma: A trans‐ancestry and drug‐target Mendelian randomization study

Z Wang, J Lu, J Hu - Liver International, 2023 - Wiley Online Library
Abstract Background and Aims Antihypertensive drugs were recently reported to have an
oncogenic role in common cancer, however, whether these drugs would affect the risk of …

The landscape of the methodology in drug repurposing using human genomic data: a systematic review

L Wang, Y Lu, D Li, Y Zhou, L Yu… - Briefings in …, 2024 - academic.oup.com
The process of drug development is expensive and time-consuming. In contrast, drug
repurposing can be introduced to clinical practice more quickly and at a reduced cost. Over …

Novel biomarkers and emerging tools to identify causal molecular pathways in hypertension and associated cardiovascular diseases

E Józefczuk, TJ Guzik… - Polish Heart Journal …, 2023 - journals.viamedica.pl
Hypertension (HT) is a modifiable risk factor for life-threatening cardiovascular diseases
(CVDs) including coronary artery disease, heart failure, or stroke. Despite significant …

Type 1 diabetes, glycemic traits, and risk of dental caries: a Mendelian randomization study

L Tan, MM Zhong, YQ Zhao, J Zhao… - Frontiers in …, 2023 - frontiersin.org
Background: Regarding past epidemiological studies, there has been disagreement over
whether type 1 diabetes (T1DM) is one of the risk factors for dental caries. The purpose of …

Lipid-lowering drugs affect lung cancer risk via sphingolipid metabolism: a drug-target Mendelian randomization study

H Li, L Zhang, F Yang, X Feng, R Fu, R Zhao… - Frontiers in …, 2023 - frontiersin.org
Background: The causal relationship between lipid-lowering drug (LLD) use and lung
cancer risk is controversial, and the role of sphingolipid metabolism in this effect remains …

Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study

S Qin, J Wang, H Yuan, J He, S Luan, Y Deng - Frontiers in Genetics, 2024 - frontiersin.org
Observational studies have shown an association between liver dysfunction and
hepatocellular carcinoma (HCC), but the causality relationship between them is unclear. We …